There are currently 387 million people worldwide living with diabetes. Diabetics cannot survive without insulin. While most diabetics here in the U.S. have access to insulin, those in poorer communities and regions often go without insulin due to cost or bureaucracy. As a result, many go without and suffer complications including blindness, cardiovascular disease, amputations, nerve and kidney damage, and eventually death. The few suppliers of insulin have meanwhile been raising prices in near-synchrony for decades, placing insulin further and further out of reach of many who need it and leading to rationing, and severe long-term health consequences. We're doing the research and development necessary to put insulin production under the control of the people who need it to survive and restore access to this crucial drug.